| Document Date: 2011-10-27 01:41:01
Open Document File Size: 164,90 KBShare Result on Facebook
Company Graylands Hospital Drug Bulletin / / Country United States / Australia / / / Event FDA Phase / / IndustryTerm treatment of depressive disorders / treatment of depression / energy drinks / food / energy / treatment of major depressive disorder / / MedicalCondition insomnia / ADHD / major depressive disorder / depressive disorders / Schizophrenia Cognitive dysfunction / Tourette syndrome / schizophrenia / bipolar depression / psychostimulants4 Cataplexy / co-morbid motor tics / psychiatric illness / disturbed Narcolepsy / narcolepsy / sexual dysfunction / chronic daytime sleepiness / attention deficit hyperactivity disorder / fatigue / mental illness / hypopnoea Attention Deficit Hyperactivity Disorder ADHD / Narcolepsy Narcolepsy / bipolar affective disorder / depression / cataplexy / / Organization Metropolitan Area Health Service / Department of Health / Graylands Pharmacy Department / / Person Babu Mathew References / Katie Walker / / Position Governor / Major / / Product venlafaxine / fluoxetine / Ritalin LA / Concerta / modafinil / 25mg / Action Agomelatine / ciprofloxacin / zolpidem / Valdoxan® / / ProvinceOrState Western Australia / / Region Western Australia / / Technology Pharmacokinetics / /
SocialTag |
Psychostimulants in Psychiatry. Graylands Hospital Drug Bulletin